John E. Davis - 23 Feb 2024 Form 4/A Insider Report for ARTIVION, INC. (AORT)

Reporting relationship: Chief Commercial Officer
Issuer ticker: AORT
Reported as of: 23 Feb 2024
Net transaction value: -$70,158
SEC form: 4/A
Accepted by SEC: 14 Mar 2024, 20:27:15 UTC
Original report date: 28 Feb 2024
Prior SEC filing: 22 Feb 2024
Next SEC filing: 29 Feb 2024
Source filing: View source filing
Reporting owner signature: /s/ John E. Davis

Key filing fact

John E. Davis filed Form 4/A for ARTIVION, INC. (AORT) on 14 Mar 2024.

Key facts

This page summarizes John E. Davis's Form 4/A filing for ARTIVION, INC. (AORT).
4 reported transactions and 0 derivative rows are listed below.
Accepted by SEC: 14 Mar 2024, 20:27.

Change

Previous filing in this sequence was filed on 22 Feb 2024.
Current net transaction value: -$70,158.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4/A disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

AORT transaction

Common Stock

Award

Transaction value: $0
Shares: +5,386
Change %: +3.6%
Price: $0.000000
Shares after: 153,279
Date: 23 Feb 2024
Ownership: Direct
Footnotes: F1

AORT transaction

Common Stock

Sale

Transaction value: $32,150
Shares: -1,586
Change %: -1%
Price: $20.27
Shares after: 151,711
Date: 26 Feb 2024
Ownership: Direct
Footnotes: F2, F3

AORT transaction

Common Stock

Award

Transaction value: $0
Shares: +12,736
Change %: +8.4%
Price: $0.000000
Shares after: 164,447
Date: 23 Feb 2024
Ownership: Direct
Footnotes: F3, F4

AORT transaction

Common Stock

Sale

Transaction value: $38,008
Shares: -1,875
Change %: -1.1%
Price: $20.27
Shares after: 162,572
Date: 26 Feb 2024
Ownership: Direct
Footnotes: F3, F5

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 5 footnotes

Footnote F1

Represents performance stock units granted on Feb. 22, 2023. One hundred percent (100%) were issued on Feb. 23, 2024.

Footnote F2

These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,610 shares were sold, when in fact, 1,586 shares were sold.

Footnote F3

As a result of the administrative error in reporting the number of shares sold in the sell to cover transactions on February 26, 2024, the number of shares reported as beneficially owned in this amendment reflects an increase in the number of shares reported as beneficially owned in the original Form 4.

Footnote F4

Represents performance stock units granted on Feb. 22, 2023. Fifty percent (50%) were issued on Feb. 23, 2024. The remaining shares earned in connection with the Feb. 2023 grant will be eligible to vest and be issued as follows: 25% on 02/22/2025; and 25% on 02/22/2026, assuming employment on the relevant vesting date.

Footnote F5

These shares were sold upon the vesting of performance stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. This amendment is being filed to address an administrative error in reporting the number of shares sold in the sell to cover transaction on February 26, 2024. The original Form 4 reported that 1,904 shares were sold, when in fact, 1,875 shares were sold.